share_log

VOXX International Corporation Announces Joint Venture Between EyeLock LLC and GalvanEyes Partners LLC

VOXX International Corporation Announces Joint Venture Between EyeLock LLC and GalvanEyes Partners LLC

VOXX 国际公司宣布 EyeLock LLC 和 GalvanEyes Partners LLC
奥迪富斯 ·  03/07 00:00

Companies reach agreement to engage in a joint venture and form new entity – BioCenturion, LLC

各公司达成协议,成立合资企业并成立新实体— BioCenturion, LLC

ORLANDO, Fla., March 7, 2024 /PRNewswire/ -- VOXX International Corporation (NASDAQ: VOXX), a leading manufacturer and distributor of automotive and consumer technologies for the global markets, today announced that its majority owned subsidiary, EyeLock LLC, has entered into a joint venture agreement (the "Agreement") with GalvanEyes Partners LLC to form BioCenturion, LLC. The combination of both companies will create a stronger and more streamlined organization bringing together technology, R&D, sales, marketing, and business development under one roof, while opening new avenues for growth.

佛罗里达州奥兰多,2024年3月7日 /PRNewswire/ — 全球市场领先的汽车和消费技术制造商和分销商VOXX国际公司(纳斯达克股票代码:VOXX)今天宣布,其控股子公司EyeLock LLC已与GalvanEyes Partners LLC签订合资协议(“协议”),组建BioCenturion, LLC。两家公司的合并将创建一个更强大、更精简的组织,将技术、研发、销售、营销和业务发展整合到一个屋檐下,同时开辟新的增长途径。

Under the Agreement, both companies will be contributing selected assets and liabilities to the joint venture. GalvanEyes will serve as the managing member and will be responsible for all working capital needs over the next two years, after which, the companies will evaluate the best path forward for the business. The new entity will be run by Allen Ibaugh, who served both as President of EyeLock and CEO of GalvanEyes and will combine and manage the talent from both organizations. BioCenturion has been structured as a 50/50 joint venture, whereby GalvanEyes will manage all day-to-day business operations and EyeLock will have veto rights as it relates to various fundamental company matters, including, but not limited to, amendments to the operating agreement, the admission of new members, future financing arrangements, potential acquisitions, or the potential sale of the business. In the event of a capital event as defined therein and based on the respective capital contributions to date and expected, the first $45.0 million from a capital event would get preferential distribution rights with ~77% going to EyeLock and ~23% to GalvanEyes, and the remaining portion split evenly between the companies. EyeLock will retain the liability of the approximate $70 million Note due to VOXX, which is not part of this transaction.

根据该协议,两家公司将向合资企业出资选定的资产和负债。GalvanEyes将担任管理成员,并将负责未来两年的所有营运资金需求,之后,两家公司将评估业务的最佳前进方向。新实体将由艾伦·伊博经营,他曾担任EyeLock总裁兼GalvanEyes首席执行官,并将整合和管理这两个组织的人才。BioCenturion的结构是50/50的合资企业,GalvanEyes将管理所有日常业务运营,EyeLock将拥有与各种基本公司事务相关的否决权,包括但不限于运营协议的修订、新成员的接纳、未来的融资安排、潜在的收购或可能的业务出售。如果发生其中定义的资本事件,根据迄今为止和预期的相应资本出资,资本事件的首批4,500万美元将获得优先分配权,其中约77%将分配给EyeLock,约23%归GalvanEyes,其余部分由两家公司平均分配。EyeLock将保留应付给VOXX的大约7000万美元票据的负债,这不是本次交易的一部分。

In conjunction with this transaction, Beat Kahli has stepped down as President of VOXX but will continue to serve as co-Vice Chairman of the Company's Board of Directors. Further and as previously announced, effective March 1, 2024, Loriann Shelton assumed the role of Chief Financial Officer of VOXX, replacing Michael Stoehr, who served in this position for over 40 years. Mr. Stoehr will remain with the company as Senior Vice President and Treasurer and has stepped down from the Board as a Director. Additionally, Mr. Kahli will serve as Chairman of the Board and Chief Executive Officer of BioCenturion, enabling him to spend more time unlocking value in this new entity, while continuing to support VOXX and its shareholders at the Board level.

在这笔交易中,Beat Kahli已辞去VOXX总裁的职务,但将继续担任公司董事会联席副主席。此外,正如先前宣布的那样,洛里安·谢尔顿自2024年3月1日起担任VOXX首席财务官,接替在该职位上任职40多年的迈克尔·斯托尔。Stoehr先生将继续留在公司担任高级副总裁兼财务主管,并已辞去董事会董事职务。此外,卡利先生将担任BioCenturion的董事会主席兼首席执行官,这使他能够花更多的时间在这个新实体中释放价值,同时继续在董事会层面支持VOXX及其股东。

Commenting on the joint venture and executive changes, Pat Lavelle, Chief Executive Officer of VOXX International stated, "With respect to the joint venture, I believe this is a win-win situation for the Company. VOXX no longer will be responsible for the operating costs needed to support EyeLock, while retaining much of the upside of EyeLock's potential. Our Biometrics segment has recorded losses since its inception and while we have several large opportunities in development and on the horizon, the business is expected to generate losses near-term. By structuring the JV as we did, we can reallocate capital and generate further savings for VOXX. With respect to Beat's transition, this too is a positive for shareholders. His goal as President was to secure strategic partnerships for VOXX and he will continue to do so. Beat will focus on driving this partnership forward and supporting VOXX as he has in the past, while building BioCenturion into a competitive force in the biometrics industry."

VOXX International首席执行官帕特·拉维尔在评论合资企业和高管变动时表示:“就合资企业而言,我认为这对公司来说是一个双赢的局面。VOXX将不再承担支持EyeLock所需的运营成本,同时保留了EyeLock潜力的大部分上行空间。我们的生物识别领域自成立以来就出现了亏损,尽管我们在开发和将来都有许多巨大的机会,但预计该业务将在短期内造成亏损。通过像我们一样组建合资企业,我们可以重新分配资本,为VOXX节省更多资金。就Beat的过渡而言,这对股东来说也是一个积极因素。他作为总裁的目标是确保VOXX的战略伙伴关系,他将继续这样做。Beat将专注于推动这种伙伴关系向前发展,一如既往地支持VOXX,同时将BioCenturion打造成生物识别行业的竞争力量。”

Beat Kahli added, "What initially drove me to investing in VOXX was biometrics, and I have continued to invest over the years as I saw tremendous opportunities for value creation amongst VOXX's various businesses. I also believed that Pat and the VOXX team could unlock the value inside EyeLock. After a year of working closely at VOXX, I feel the Company and its shareholders, myself included, would be best served if I focused my attention on building a strong Biometrics business with cutting-edge technology that generates returns, while continuing to work on strategic partnerships for VOXX. I saw value in EyeLock years ago which is what prompted the formation of GalvanEyes. Now, we have a chance to combine the companies' respective strengths and turn our vision into reality, which will increase value for BioCenturion and for VOXX shareholders."

Beat Kahli补充说:“最初促使我投资VOXX的是生物识别技术,多年来我一直在投资,因为我看到了VOXX各种业务中创造价值的巨大机会。我还相信 Pat 和 VOXX 团队可以解锁 EyeLock 中的价值。在VOXX密切合作了一年之后,我认为,如果我将注意力集中在利用可带来回报的尖端技术建立强大的生物识别业务上,同时继续为VOXX建立战略合作伙伴关系,将对公司及其股东,包括我自己,最有利。几年前我看到了eyeLock的价值,这正是促使GalvanEyes成立的原因。现在,我们有机会结合两家公司各自的优势,将我们的愿景变为现实,这将增加BioCenturion和VOXX股东的价值。”

About VOXX International Corporation
VOXX International Corporation (NASDAQ: VOXX) has grown into a leader in Automotive Electronics and Consumer Electronics, with emerging Biometrics technology to capitalize on the increased need for advanced security. Over the past several decades, with a portfolio of approximately 35 trusted brands, VOXX has built market-leading positions in in-vehicle entertainment, automotive security, reception products, a number of premium audio market segments, and more. VOXX is a global company, with an extensive distribution network that includes power retailers, mass merchandisers, 12-volt specialists and many of the world's leading automotive manufacturers. For additional information, please visit our website at www.voxxintl.com.

关于 VOXX 国际公司
VOXX International Corporation(纳斯达克股票代码:VOXX)已成长为汽车电子和消费电子领域的领导者,凭借新兴的生物识别技术来利用对高级安全性日益增长的需求。在过去的几十年中,VOXX拥有约35个值得信赖的品牌,在车载娱乐、汽车安全、接收产品、许多高端音频细分市场等领域建立了市场领先地位。VOXX 是一家跨国公司,拥有广泛的分销网络,其中包括电力零售商、批量销售商、12 伏特专家和许多世界领先的汽车制造商。欲了解更多信息,请访问我们的网站 www.voxxintl.com

About EyeLock
As a market leader of biometric identity authentication solutions, EyeLock specializes in creating and deploying authentication solutions to help clients secure their worlds, optimize their workload, and organize their data through customized biometric solutions. The company's significant IP portfolio, including more than 100 patents granted, patents pending, and proprietary technology enables a high-speed, convenient, touchless, contactless, frictionless, and secure authentication of individuals across different business verticals.

关于 EyeLock
作为生物识别身份认证解决方案的市场领导者,EyeLock专门创建和部署身份验证解决方案,以帮助客户保护他们的世界,优化工作负载,并通过定制的生物识别解决方案组织数据。该公司重要的知识产权组合,包括100多项已授予的专利、正在申请的专利和专有技术,可实现对不同业务垂直领域的个人进行高速、便捷、非接触、非接触式、无摩擦和安全的身份验证。

The strength of EyeLock is our people and their ideas. Our clients come to us for solutions to solve their security and software challenges. Our staff understands technology like no other firm. Through the years we have built an interdisciplinary team who are experts in their fields and cross trained for responsiveness and adaptability.

EyeLock 的优势在于我们的员工和他们的想法。我们的客户向我们寻求解决方案,以解决他们的安全和软件挑战。我们的员工对技术的理解是其他公司所无法比拟的。多年来,我们建立了一支跨学科团队,他们是各自领域的专家,经过交叉培训,提高了响应能力和适应能力。

About GalvanEyes Partners
GalvanEyes specializes in creating and deploying authentication solutions to help clients secure their worlds, optimize their workload, and organize their data through customized Biometric solutions. Its experience as a solutions provider in multiple information technology-related industries dates back to 2004; and our experience over this time provides GalvanEyes a strong reputation of providing strategy, product development, marketing, sales, and distribution proficiency to biometric identity authentication solutions. The strength of GalvanEyes is our people and their ideas. Our clients come to us for solutions to solve their security and software challenges. Our staff understands technology like no other firm. Through the years, we have built an interdisciplinary team who are experts in their fields and cross-trained for responsiveness and adaptability.

关于 GalvanEyes 合作伙伴
GalvanEyes 专门创建和部署身份验证解决方案,以帮助客户保护他们的世界,优化工作负载,并通过定制的生物识别解决方案组织数据。它作为多个信息技术相关行业的解决方案提供商的经验可以追溯到2004年;我们在这段时间内的经验使GalvanEyes在为生物识别身份认证解决方案提供战略、产品开发、营销、销售和分销方面享有良好的声誉。GalvanEyes 的优势在于我们的员工和他们的想法。我们的客户向我们寻求解决方案,以解决他们的安全和软件挑战。我们的员工对技术的理解是其他公司所无法比拟的。多年来,我们建立了一支跨学科团队,他们是各自领域的专家,并接受过交叉培训,以提高响应能力和适应能力。

Safe Harbor Statement
Except for historical information contained herein, statements made in this release constitute forward-looking statements and thus may involve certain risks and uncertainties. All forward-looking statements made in this release are based on currently available information and the Company assumes no responsibility to update any such forward-looking statements. The following factors, among others, may cause actual results to differ materially from the results suggested in the forward-looking statements. The factors include, but are not limited to the risk factors described in the "Risk Factors" section of the Company's Annual Report on Form 10-K for the fiscal year ended February 28, 2023, and other filings made by the Company from time to time with the SEC, as such descriptions may be updated or amended in any future reports we file with the SEC. The factors described in such SEC filings include, without limitation: impacts related to the COVID-19 pandemic, global supply shortages and logistics costs and delays; global economic trends; cybersecurity risks; risks that may result from changes in the Company's business operations; operational execution by our businesses; changes in law, regulation or policy that may affect our businesses; our ability to increase margins through implementation of operational improvements, restructuring and other cost reduction methods; our ability to keep pace with technological advances; significant competition in the automotive electronics, consumer electronics and biometrics businesses; our relationships with key suppliers and customers; quality and consumer acceptance of newly introduced products; market volatility; non-availability of product; excess inventory; price and product competition; new product introductions; foreign currency fluctuations; and restrictive debt covenants. Many of the foregoing risks and uncertainties are, and will be, exacerbated by the War in the Ukraine and any worsening of the global business and economic environment as a result.

安全港声明
除此处包含的历史信息外,本新闻稿中的陈述均构成前瞻性陈述,因此可能涉及某些风险和不确定性。本新闻稿中的所有前瞻性陈述均基于当前可用信息,公司不承担更新任何此类前瞻性陈述的责任。除其他外,以下因素可能导致实际业绩与前瞻性陈述中建议的结果存在重大差异。这些因素包括但不限于公司截至2023年2月28日财年的10-K表年度报告的 “风险因素” 部分中描述的风险因素,以及公司不时向美国证券交易委员会提交的其他文件,因为此类描述可能会在我们向美国证券交易委员会提交的任何未来报告中更新或修改。美国证券交易委员会此类文件中描述的因素包括但不限于:与 COVID-19 疫情相关的影响、全球供应短缺以及物流成本和延误;全球经济趋势;网络安全风险;公司业务运营变化可能产生的风险;我们业务的运营执行;可能影响我们业务的法律、法规或政策变化;我们通过实施运营改进、重组和其他成本降低方法来增加利润的能力;我们跟上步伐的能力技术进步;汽车电子、消费电子和生物识别业务的激烈竞争;我们与主要供应商和客户的关系;新推出产品的质量和消费者接受度;市场波动;产品不可用;库存过剩;价格和产品竞争;新产品推出;外币波动;限制性债务契约。乌克兰战争以及由此导致的全球商业和经济环境的恶化加剧了上述许多风险和不确定性,并将继续加剧。

Investor Relations Contact:
Glenn Wiener, GW Communications (for VOXX)
Email: gwiener@GWCco.com

投资者关系联系人:
格伦·维纳,GW Communications(适用于 VOXX)
电子邮件: gwiener@GWCco.com

SOURCE VOXX International Corporation (NASDAQ:VOXX)

来源 VOXX 国际公司(纳斯达克股票代码:VOXX)

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发